Mercilon

Leaflet accompanying the packaging: user information

Warning! Keep the leaflet, information on the immediate packaging in a foreign language!

Mercilon

0.15 mg + 0.02 mg, tablets
Desogestrel + Ethinylestradiol

Important information about combined hormonal contraceptives

• If used correctly, they are one of the most reliable, reversible methods of contraception.
• To a small extent, they increase the risk of blood clots in veins and arteries, especially in the first year of use or after resuming use after a break of 4 weeks or more.
• Caution should be exercised and a doctor should be consulted if the patient suspects that symptoms of blood clots have occurred (see section 2 "Blood clots").

You should carefully read the contents of the leaflet before using the medicine, as it contains important information for the patient.

• You should keep this leaflet so that you can read it again if necessary.
• In case of any doubts, you should consult a doctor or pharmacist.
• This medicine has been prescribed to a specific person. It should not be given to others. The medicine may harm another person, even if the symptoms of their illness are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of contents of the leaflet

• 1. What is Mercilon and what is it used for
• 2. Important information before using Mercilon
• 2.1 When not to use Mercilon
• 2.2 When to exercise special caution when using Mercilon
• 2.3 When to consult a doctor
• 3. How to use Mercilon
• 3.1 When and how to take the tablets
• 3.2 Starting the first pack of Mercilon
• 3.3 Using more than the recommended dose of Mercilon
• 3.4 What to do in case of…
• 3.5 Stopping Mercilon
• 4. Possible side effects
• 5. How to store Mercilon
• 6. Contents of the packaging and other information
• 6.1 What Mercilon contains
• 6.2 What Mercilon looks like and what the packaging contains
• 6.3 Marketing authorization holder and manufacturer
• 6.4 Date of approval of the leaflet

1. What is Mercilon and what is it used for

Mercilon is a combined oral contraceptive. Each tablet contains a small dose of two different female hormones. These are desogestrel (progestogen) and ethinylestradiol (estrogen). Due to the small hormone content, Mercilon is called a low-dose contraceptive pill. Mercilon belongs to the group of monophasic, combined oral contraceptives, as all the tablets in the packaging contain the same amount of hormones.
Mercilon is used to prevent pregnancy.
The method of oral contraception is a very effective method of birth control. The possibility of becoming pregnant while taking contraceptive tablets (provided that the patient does not forget to take the tablets) is very small.

2. Important information before using Mercilon

General notes

Before starting to take Mercilon, you should read the information about blood clots in section 2. It is especially important to read about the symptoms of blood clots (see section 2 "Blood clots").
Most of the situations described in this leaflet indicate when you should stop taking the tablet or when the effectiveness of the tablet may be reduced. In these situations, you should refrain from sexual intercourse or use additional, non-hormonal contraceptive methods, such as a condom or another mechanical method. You should not use the calendar method or the temperature measurement method. These methods may be ineffective because contraceptive tablets cause changes in temperature and cervical mucus that occur during the menstrual cycle.

Mercilon, like other contraceptive tablets, does not protect against HIV (AIDS) and other sexually transmitted diseases.

Mercilon is prescribed by a doctor individually for each patient. You should not give Mercilon to others.
Mercilon should not be used to delay the start of bleeding.
In exceptional cases, when there is a need to delay the day of bleeding, you should consult a doctor.

2.1 When not to use Mercilon

You should not use Mercilon if you have any of the conditions listed below. If you have any of the conditions listed below, you should inform your doctor. The doctor will discuss with you which other contraceptive method will be more suitable for you.

• if you are allergic to the active substances or any of the other ingredients of this medicine (listed in section 6);
• if you currently have (or have ever had) a blood clot in the veins of the legs (deep vein thrombosis), lungs (pulmonary embolism), or other organs;
• if you know you have blood coagulation disorders, such as protein C deficiency, protein S deficiency, antithrombin III deficiency, factor V Leiden, or antiphospholipid antibodies;
• if you need to have surgery or will be immobilized for a long time (see section 2 "Blood clots");
• if you have had a heart attack or stroke;
• if you have (or have had) angina pectoris (a disease that causes severe chest pain and may be the first symptom of a heart attack) or a transient ischemic attack (temporary stroke symptoms);
• if you have any of the following diseases that may increase the risk of a blood clot in an artery:
• severe diabetes with blood vessel damage
• very high blood pressure
• very high levels of fats in the blood (cholesterol or triglycerides)
• hyperhomocysteinemia
• if you have (or have had) a type of migraine called "migraine with aura";
• if you have (or have had) pancreatitis associated with severe hypertriglyceridemia;
• if you have jaundice or severe liver disease;
• if you have (or have had) a hormone-dependent malignant tumor (e.g., breast or genital organ cancer);
• if you have (or have had) a benign or malignant liver tumor;
• if you have unexplained vaginal bleeding;
• if you have endometrial hyperplasia (abnormal growth of the uterine lining);
• if you are pregnant or breastfeeding;
• if you have a hepatitis C virus infection and are taking medicines containing ombitasvir, paritaprevir, ritonavir, and dasabuvir, or glecaprevir and pibrentasvir (see also section "Mercilon and other medicines").

If any of the above conditions occur for the first time while using Mercilon, you should stop using the medicine and consult a doctor, and use a non-hormonal contraceptive method (see also section 2 "General notes").

2.2 When to exercise special caution when using Mercilon

Before starting to use Mercilon, you should discuss it with your doctor or pharmacist.
When should you contact your doctor?
You should see your doctor immediately

• if you notice possible symptoms of a blood clot, which may indicate that you have a blood clot in your leg (deep vein thrombosis), blood clots in your lungs (pulmonary embolism), a heart attack, or a stroke (see below "Blood clots (thrombosis)").

To find a description of the serious side effects mentioned, see "How to recognize a blood clot".

You should tell your doctor if you have any of the following conditions.

If these symptoms occur or worsen while using Mercilon, you should also tell your doctor.

• if you smoke;
• if you have diabetes;
• if you are overweight;
• if you have high blood pressure;
• if you have heart valve problems or heart rhythm disorders;
• if you have superficial thrombophlebitis (inflammation of the veins under the skin);
• if you have varicose veins;
• if you have a history of blood clots, heart attack, or stroke in your immediate family;
• if you have migraines;
• if you have epilepsy;
• if you have high levels of fats in the blood (hypertriglyceridemia) or a family history of this condition. Hypertriglyceridemia is associated with an increased risk of developing pancreatitis;
• if you need to have surgery or will be immobilized for a long time (see section 2 "Blood clots");
• if you are immediately after childbirth, as you are at increased risk of blood clots. You should consult your doctor for information on how soon you can start taking Mercilon after childbirth;
• if you have a history of breast cancer in your immediate family;
• if you have liver or gallbladder disease;
• if you have Crohn's disease or ulcerative colitis (chronic inflammatory bowel diseases);
• if you have systemic lupus erythematosus (a disease that affects the body's natural defense system);
• if you have hemolytic uremic syndrome (a blood clotting disorder that causes kidney failure);
• if you have sickle cell anemia (a genetic disorder that affects red blood cells);
• if you have experienced any of the following conditions for the first time during pregnancy or previous use of hormonal contraception: hearing loss, porphyria, herpes during pregnancy, Sydenham's chorea;
• if you experience symptoms of angioedema, such as facial swelling, tongue and/or throat swelling, and/or difficulty swallowing or hives with difficulty breathing, you should see your doctor immediately. Products containing estrogens may cause or worsen symptoms of hereditary and acquired angioedema.
• if you have chloasma (yellow-brown skin discoloration, especially on the face) currently or in the past; in these cases, you should avoid sun exposure or ultraviolet radiation.

If any of the above factors occur for the first time while using the tablets, you should contact your doctor immediately.

2.2.1 Hormonal contraception and blood clotting disorders

BLOOD CLOTS

The use of combined hormonal contraceptives, such as Mercilon, is associated with an increased risk of blood clots compared to not using the therapy.
Blood clots can occur

• in the veins (also known as "venous thrombosis" or "venous thromboembolism")
• in the arteries (also known as "arterial thrombosis" or "arterial thromboembolism").

Not everyone recovers fully from a blood clot. In rare cases, the effects of a blood clot can be long-term or, very rarely, fatal.

Remember that the overall risk of developing harmful blood clots due to Mercilon is small.

HOW TO RECOGNIZE A BLOOD CLOT

You should see your doctor immediately if you notice any of the following symptoms.
Are you experiencing any of these symptoms?
Why might you be suffering from

• swelling of the leg or swelling along a vein in the leg or foot, especially if it is accompanied by:
• pain or tenderness in the leg, which may only be felt when standing or walking;
• increased temperature in the affected leg;
• skin discoloration, such as pallor, redness, or cyanosis. Deep vein thrombosis
• sudden unexplained shortness of breath or rapid breathing;
• sudden unexplained cough, which may be accompanied by coughing up blood;
• sharp chest pain, which may worsen with deep breathing;
• severe dizziness or fainting;
• rapid or irregular heartbeat;
• severe abdominal pain.

If you are unsure, you should see your doctor, as some of these symptoms, such as coughing or shortness of breath, may be mistaken for less serious conditions, such as a respiratory infection (e.g., a cold).
Pulmonary embolism
Most symptoms occur in one eye:

• sudden loss of vision or
• painless vision disturbances, which may lead to loss of vision

What can happen if a blood clot forms in a vein?

• The use of combined hormonal contraceptives is associated with an increased risk of developing blood clots in the veins (venous thrombosis). Although these side effects are rare, they most often occur in the first year of using combined hormonal contraceptives.
• If blood clots form in the veins in the leg or foot, it can lead to the development of deep vein thrombosis.
• If a blood clot moves from the leg and settles in the lungs, it can cause a pulmonary embolism.
• In very rare cases, a blood clot can form in another organ, such as the eye (retinal vein thrombosis).

When is the risk of developing a blood clot in a vein highest?

The risk of developing a blood clot in a vein is highest during the first year of using combined hormonal contraceptives for the first time. The risk may also be higher when resuming the use of combined hormonal contraceptives (the same or a different medicine) after a break of 4 weeks or more.
After the first year, the risk decreases, but it is always higher compared to not using combined hormonal contraceptives.
If you stop using Mercilon, the risk of developing blood clots returns to normal within a few weeks.

What factors increase the risk of developing a blood clot in a vein?

The risk of developing a blood clot due to Mercilon is small, but some factors can increase this risk. The risk is higher:

• if you are severely overweight (body mass index (BMI) over 30 kg/m2);
• if someone in your immediate family has had a blood clot in the legs, lungs, or other organs at a young age (e.g., under 50 years old). In this case, you may have a genetic blood clotting disorder;
• if you need to have surgery, are immobilized for a long time due to injury or illness, or have a leg in a cast. You may need to stop using Mercilon for a few weeks before surgery or immobilization. If you need to stop using Mercilon, you should ask your doctor when you can resume using the medicine;
• with age (especially over 35 years old);
• if you have recently given birth.

The risk of developing a blood clot increases with the number of risk factors present in the patient.
Taking a long-haul flight (>4 hours) may temporarily increase the risk of developing a blood clot, especially if you have another risk factor.
It is essential to tell your doctor if any of the above factors apply to you, even if you are unsure. Your doctor may decide to stop using Mercilon.
You should inform your doctor if any of the above conditions change while using Mercilon, e.g., if you start smoking, if someone in your immediate family is diagnosed with a blood clot without a known cause, or if you gain weight significantly.

BLOOD CLOTS IN ARTERIES

What can happen if a blood clot forms in an artery?

Similarly to blood clots in veins, blood clots in arteries can have serious consequences, such as a heart attack or stroke.

Factors that increase the risk of developing a blood clot in an artery

It is essential to note that the risk of a heart attack or stroke associated with Mercilon is very small, but it may increase:

• with age (over about 35 years old);
• if you smoke.While using a hormonal contraceptive like Mercilon, it is recommended to quit smoking. If you are unable to quit smoking and are over 35 years old, your doctor may recommend using a different type of contraception;
• if you are overweight;
• if you have high blood pressure;
• if someone in your immediate family has had a heart attack or stroke at a young age (under 50 years old). In this case, you may also be at increased risk of having a heart attack or stroke;
• if you or someone in your immediate family has high levels of fats in the blood (cholesterol or triglycerides);
• if you have migraines, especially migraines with aura;
• if you have heart disease (valve damage, heart rhythm disorder called atrial fibrillation);
• if you have diabetes. If you have more than one of the above conditions or if any of them are severe, the risk of developing a blood clot may be even higher.

You should inform your doctor if any of the above conditions change while using Mercilon, e.g., if you start smoking, if someone in your immediate family is diagnosed with a blood clot without a known cause, or if you gain weight significantly.

2.2.2 Hormonal contraception and cancer

Women using contraceptive tablets have a slightly higher incidence of breast cancer than women of the same age who do not use them. This small increase in the incidence of breast cancer disappears gradually within 10 years of stopping the use of contraceptive tablets. It is not known whether this difference is caused by the use of contraceptive tablets. It may be related to the fact that women using contraceptive tablets are more likely to have medical check-ups and breast cancer is diagnosed earlier in them.
In very rare cases, women using contraceptive tablets have been found to have benign liver tumors, and even more rarely, malignant tumors. These tumors can cause bleeding into the abdominal cavity. If you experience severe abdominal pain, you should see your doctor immediately.
Chronic infection with the human papillomavirus (HPV) is the most significant risk factor for cervical cancer. It is thought that cervical cancer may occur slightly more frequently in women who have used contraceptive tablets for an extended period. This may not be caused by the contraceptive tablets. It is likely related to sexual behavior or other factors.

Psychiatric disorders

Some women using hormonal contraceptives, including Mercilon, have reported depression or low mood. Depression can be severe and sometimes lead to suicidal thoughts. If mood changes and symptoms of depression occur, you should see your doctor as soon as possible for further medical advice.

2.2.3 Mercilon and other medicines

You should always tell your doctor about the medicines or herbal products you are currently using. You should also inform your doctor or another doctor prescribing other medicines (or pharmacist) that you are using Mercilon. They may inform you about the need to use an additional contraceptive method (e.g., a condom), and if so, for how long, and whether it is necessary to modify the use of another medicine.
Some medicines

• may affect the level of Mercilon in the blood
• may reduce its contraceptive effectiveness
• may cause unexpected bleedingThis applies to medicines used to treat:
• epilepsy (e.g., primidone, phenytoin, phenobarbital, carbamazepine, oxcarbazepine, topiramate, felbamate);
• tuberculosis (e.g., rifampicin, rifabutin);
• HIV infection (e.g., ritonavir, nelfinavir, nevirapine, efavirenz);
• hepatitis C virus infection (e.g., boceprevir, telaprevir);
• other infectious diseases (e.g., griseofulvin);
• high blood pressure in the blood vessels of the lungs (bosentan);
• depressive moods (St. John's wort (Hypericum perforatum)).

If you are taking medicines or herbal products that may reduce the effectiveness of Mercilon, you should use a mechanical contraceptive method as well. Due to the fact that the effect of another medicine on Mercilon may persist for up to 28 days after stopping the medicine, it is necessary to use additional mechanical contraception during this time.
Mercilon may affect the actionof other medicines, such as for example

• cyclosporine
• the antiepileptic drug lamotrigine (this may lead to an increased frequency of seizures)If you have a hepatitis C virus infection and are taking medicines containing ombitasvir, paritaprevir, ritonavir, and dasabuvir, or glecaprevir and pibrentasvir, you should not use Mercilon, as it may cause an increase in liver function test results in the blood (increase in liver enzyme ALT)

Before starting to use these medicines, your doctor will prescribe a different type of contraceptive.
You can resume using Mercilon about 2 weeks after finishing this treatment.
See section "When not to use Mercilon".

2.2.4 Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, you should ask your doctor or pharmacist for advice before using this medicine.
Mercilon is contraindicated in pregnancy.
If you suspect you are pregnant while using Mercilon, you should see your doctor immediately.
Mercilon is not recommended during breastfeeding.
If you want to use Mercilon during breastfeeding, you should consult your doctor.

2.2.5 Driving and using machines

Using Mercilon does not affect your ability to drive or use machines.

2.2.6 Mercilon contains lactose monohydrate

If you have been diagnosed with an intolerance to some sugars, you should contact your doctor before taking Mercilon.

2.2.7 Use in children and adolescents

There are no available clinical data on the efficacy and safety of using Mercilon in children and adolescents under 18 years of age.

2.3 When to consult a doctor

Regular check-ups
Women using contraceptive tablets should be informed by their doctor about the need for regular medical check-ups. These check-ups are usually performed once a year.
You should see your doctor immediately in the following cases:

• if you notice possible symptoms of a blood clot, which may indicate that you have a blood clot in your leg (deep vein thrombosis), blood clots in your lungs (pulmonary embolism), a heart attack, or a stroke (see above "Blood clots"). To find a description of the serious side effects mentioned, see "How to recognize a blood clot";
• if there are any changes in your health, especially the conditions mentioned earlier in this leaflet (see sections "When not to use Mercilon" and "Important information before using Mercilon"), not forgetting the information related to the health of your immediate family that may affect the use of contraceptive tablets;
• in case of a breast lump;
• if you experience symptoms of angioedema, such as facial swelling, tongue and/or throat swelling, and/or difficulty swallowing or hives with difficulty breathing (see also section 2.2 "When to exercise special caution when using Mercilon");
• in case of planned surgery or immobilization (you should consult your doctor at least 4 weeks in advance);
• if you experience irregular, heavy vaginal bleeding;
• if you missed a tablet in the first week of use and had sexual intercourse in the previous 7 days;
• if you experience severe diarrhea;
• if you do not have your period twice in a row or if you suspect you are pregnant (you should not start the next pack without consulting your doctor).

3. How to use Mercilon

This medicine should always be used as directed by your doctor. If you are unsure, you should consult your doctor or pharmacist.

3.1 When and how to take the tablets

The packaging of Mercilon contains 21 tablets. Each tablet has a symbol of the day of the week on which it should be taken (see "Translation of the day of the week symbols on the packaging" at the end of the leaflet). The tablets should be taken at the same time every day, if necessary, with a glass of water. You should continue taking the tablets for 21 days, following the direction of the arrows. Then, you should wait 7 days without taking tablets. Menstrual bleeding (withdrawal bleeding) should occur during these 7 tablet-free days. It usually starts 2-3 days after taking the last tablet of Mercilon. You should start the next pack on the 8th day, even if you are still bleeding. This means that you will always start a new pack on the same day of the week, and your withdrawal bleeding will occur at about the same time every month.

Use in children and adolescents

There are no available clinical data on the efficacy and safety of using Mercilon in children and adolescents under 18 years of age.

3.2 Starting the first pack of Mercilon

• If you did not use any hormonal contraceptive method in the previous month

You should start taking the first tablet of Mercilon on the first day of your menstrual cycle (i.e., the first day of your period). There is no need to use an additional contraceptive method.
Taking the tablets can also be started between the 2nd and 5th day of the menstrual cycle, but in this case, you should use an additional contraceptive method (a mechanical method, e.g., a condom) for the first 7 days of taking the tablets in the first cycle.

• If you used another combined hormonal contraceptive (tablets, vaginal rings, patches)

You can start taking Mercilon the next day after taking the last active tablet of your previous contraceptive. If your current contraceptive contains placebo tablets, you can start taking Mercilon the next day after taking the last active tablet (if you are unsure which tablet is the last active one, you should ask your doctor or pharmacist). You can also start taking Mercilon later, but no later than the day after you would normally start a new pack of your current contraceptive (or the day after taking the last placebo tablet of your current contraceptive). When switching from a vaginal ring or patch, you should start taking Mercilon on the day you would normally apply a new ring or patch.

• If you used a progestogen-only tablet (mini-pill)

You can stop taking the mini-pill and start taking Mercilon the next day, at the same time. You should also use an additional contraceptive method (a mechanical method) for the first 7 days of taking the tablets.

• If you used an injectable, implant, or intrauterine system releasing progestogen

You should start taking Mercilon on the day you would normally have your next injection or on the day the implant or intrauterine system is removed. You should also use an additional contraceptive method (a mechanical method, e.g., a condom) for the first 7 days of taking the tablets, if you have sexual intercourse.

• After childbirth

Your doctor may advise you to wait until your first menstrual period before starting to take Mercilon. Your doctor may also advise you to start taking the tablets earlier. If you are breastfeeding, you should discuss taking hormonal contraception with your doctor.

• After a miscarriage

Follow your doctor's advice.

3.3 Using more than the recommended dose of Mercilon

No serious harmful effects have been observed after an overdose of Mercilon. If several tablets are taken at the same time, nausea, vomiting, or vaginal bleeding may occur. If a child has taken Mercilon, you should consult a doctor.

3.4 What to do in case of…

Missing a dose of Mercilon:

• If the delay in taking a tablet is less than 12 hours, the effectiveness of the tablet is maintained. You should take the missed tablet as soon as possible and continue taking the tablets as usual.
• If the delay in taking a tablet is more than 12 hours, the effectiveness of the tablet may be reduced. The more tablets you miss, the higher the risk of reduced contraceptive effectiveness. A higher risk of pregnancy exists if you miss a tablet at the beginning or end of the cycle. Please refer to the information below (see also the diagram).

More than one missed tablet from the pack

You should consult your doctor.

1 missed tablet in the first week of use

You should take the missed tablet as soon as possible (even if it means taking two tablets at the same time), and continue taking the tablets as usual. For the next 7 days, you should use an additional contraceptive method (a mechanical method, e.g., a condom). There is a possibility of pregnancy if you have had sexual intercourse in the week before missing the tablet. You should consult your doctor.

1 missed tablet in the second week of use

You should take the missed tablet as soon as possible (even if it means taking two tablets at the same time), and continue taking the tablets as usual. The effectiveness of the tablet is maintained, and there is no need to use additional contraceptive methods. If the above condition is not met or you have missed more than one tablet, you should use an additional contraceptive method for the next 7 days.

3.5 Discontinuation of Mercilon

You can stop taking Mercilon at any time. If you do not plan to become pregnant, you should ask your doctor for another contraceptive method.
In case of planning a pregnancy, it is usually recommended to wait until the first natural menstruation after stopping the tablets, which will make it easier to determine the expected date of delivery.
In case of any further doubts related to the use of this medicine, you should consult a doctor or pharmacist.

4. Possible side effects

Like all medicines, Mercilon can cause side effects, although not everybody gets them. If you experience any side effects, especially serious or persistent ones, or changes in your health that you think are related to the use of Mercilon, you should consult a doctor.
In all women using combined hormonal contraceptives, there is an increased risk of blood clots in the veins (venous thromboembolism) or blood clots in the arteries (arterial thrombosis). For more detailed information on the various risk factors associated with the use of combined hormonal contraceptives, you should refer to section 2 "Important information before using Mercilon".
You should immediately consult a doctor if you experience symptoms of angioedema, such as swelling of the face, tongue, and/or throat, and/or difficulty swallowing or hives potentially with dyspnea (see also section 2 "Important information before using Mercilon").
Frequently(occurring more often than in 1 in 100 women, but less often than in 1 in 10 women):

• depressive mood, mood changes
• headaches
• nausea, abdominal pain
• breast pain and tenderness
• weight gain

Less frequently(occurring more often than in 1 in 1000 women, but less often than in 1 in 100 women):

• fluid retention
• decreased libido
• migraine
• vomiting
• diarrhea
• rash
• hives
• breast enlargement

Rarely(occurring more often than in 1 in 10,000 women, but less often than in 1 in 1000 women):

• harmful blood clots in a vein or artery, for example: o in the leg or foot (e.g., deep vein thrombosis) o in the lungs (e.g., pulmonary embolism) o heart attack o stroke o mini-stroke or transient stroke-like symptoms, known as a transient ischemic attack o blood clots in the liver, stomach/intestine, kidneys, or eye The risk of blood clots may be higher if you have any other risk factors (see section 2 for more information on risk factors and symptoms of blood clots)
• hypersensitivity
• increased libido
• intolerance to contact lenses
• skin diseases (erythema nodosum, erythema multiforme)
• breast discharge
• leucorrhea
• weight loss

Reporting side effects

If you experience any side effects, including those not listed in the leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Adverse Reaction Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309,
Website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help gather more information on the safety of the medicine.

5. How to store Mercilon

The medicine should be stored out of sight and reach of children.
Do not use the medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the given month.
Store at a temperature below 30°C. Do not freeze. Store in the original packaging to protect from light and moisture.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Do not use this medicine if you notice changes in the color of the tablets, crumbling of the tablets, or other visible signs of tablet degradation.

6. Package contents and other information

6.1 What Mercilon contains

The active substances of the medicine are desogestrel at a dose of 0.15 mg and ethinylestradiol at a dose of 0.02 mg.
The other ingredients are: colloidal anhydrous silica, lactose monohydrate, potato starch, povidone, stearic acid, and all-rac-α-tocopherol.

6.2 What Mercilon looks like and what the package contains

The tablets are round, biconvex, 6 mm in diameter, and marked with the code 4 below TR on one side and the inscription Organon* on the other.
21 tablets – 1 blister pack of 21 tablets.
63 tablets – 3 blister packs of 21 tablets.
PVC/Al blister pack in a laminated aluminum sachet in a cardboard box.
A cardboard sachet is attached to the packaging, in which the blister pack should be placed.
Translation of the symbols of the days of the week on the packaging:
MA – Monday
DI – Tuesday
WO – Wednesday
DO – Thursday
VR – Friday
ZA – Saturday
ZO – Sunday
To obtain more detailed information, you should contact the marketing authorization holder or the parallel importer.

6.3 Marketing authorization holder and manufacturer

Marketing authorization holder in the Netherlands, the country of export:

N.V. Organon
Kloosterstraat 6
5349 AB Oss
Netherlands

Manufacturer

N.V. Organon
Kloosterstraat 6
5349 AB Oss
Netherlands

Parallel importer:

Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź

Repackaged by:

Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Netherlands marketing authorization number, country of export: RVG 11508
Parallel import authorization number: 221/19

• 6.4 Date of leaflet approval: 07.06.2024

[Information about the trademark]